149 related articles for article (PubMed ID: 2731116)
21. Survival with breast cancer: the importance of estrogen receptor quantity.
Shek LL; Godolphin W
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):243-50. PubMed ID: 2702979
[TBL] [Abstract][Full Text] [Related]
22. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
[TBL] [Abstract][Full Text] [Related]
23. Steroid receptors in breast cancer patients. Influence of obesity and age at diagnosis.
Mehta RR; Hart G; Das Gupta TK
Anticancer Res; 1992; 12(4):1311-4. PubMed ID: 1503426
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and progesterone receptors in ovarian cancer.
Harding M; Cowan S; Hole D; Cassidy L; Kitchener H; Davis J; Leake R
Cancer; 1990 Feb; 65(3):486-91. PubMed ID: 2297640
[TBL] [Abstract][Full Text] [Related]
25. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
[TBL] [Abstract][Full Text] [Related]
26. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647
[TBL] [Abstract][Full Text] [Related]
27. The effect of age on estrogen and progesterone receptor in primary breast cancer.
Alghanem AA; Hussain S
J Surg Oncol; 1985 Sep; 30(1):29-32. PubMed ID: 4079415
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and progesterone receptors in epithelial ovarian malignancies.
Sutton GP; Senior MB; Strauss JF; Mikuta JJ
Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
[TBL] [Abstract][Full Text] [Related]
29. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.
Smyth CM; Benn DE; Reeve TS
Breast Cancer Res Treat; 1988 Apr; 11(1):45-50. PubMed ID: 3382762
[TBL] [Abstract][Full Text] [Related]
30. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.
Rosner B; Eliassen AH; Toriola AT; Hankinson SE; Willett WC; Natarajan L; Colditz GA
Breast Cancer Res Treat; 2015 Apr; 150(3):643-53. PubMed ID: 25796612
[TBL] [Abstract][Full Text] [Related]
31. Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients.
McCarthy AM; McGuire E; Bristol M; Fredricks T; Domchek SM; Armstrong K
Cancer Epidemiol; 2013 Oct; 37(5):601-5. PubMed ID: 23810747
[TBL] [Abstract][Full Text] [Related]
32. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
Fisher B; Redmond C; Fisher ER; Caplan R
J Clin Oncol; 1988 Jul; 6(7):1076-87. PubMed ID: 2856862
[TBL] [Abstract][Full Text] [Related]
33. p29 protein in breast cancer: relation between estrogen and progesterone receptors.
Artero Morà A; Lluch Hernandez A; Cano Sanchez A; Bueno Cañigral FJ; Martin Quetglas G; Alberola Candel V; Garcia-Conde Bru J
Tumori; 1989 Apr; 75(2):113-6. PubMed ID: 2741216
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen and progesterone receptors in primary breast cancer: a population study.
Gamulin S; Romić-Stojković R
Eur J Cancer; 1991; 27(4):491-5. PubMed ID: 1827727
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.
Giani C; D'Amore E; Delarue JC; Mouriesse H; May-Levin F; Sancho-Garnier H; Breccia M; Contesso G
Int J Cancer; 1986 Jan; 37(1):7-10. PubMed ID: 3000957
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer estrogen and progesterone receptors: associations with patients' clinical and epidemiologic characteristics. G.I.V.I.O. (Interdisciplinary Group for Cancer Care Evaluation), Italy.
Tumori; 1991 Dec; 77(6):472-8. PubMed ID: 1803712
[TBL] [Abstract][Full Text] [Related]
38. Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer.
Frenay M; Milano G; Formento JL; Francoual M; Moll JL; Namer M
Eur J Cancer; 1991; 27(2):115-8. PubMed ID: 1827270
[TBL] [Abstract][Full Text] [Related]
39. Hormonal receptors in locally advanced breast cancer: change with response to neoadjuvant chemotherapy?
Morris DM; Edwards J; Gelder F
J Surg Oncol; 1991 Mar; 46(3):156-8. PubMed ID: 2011025
[TBL] [Abstract][Full Text] [Related]
40. The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix.
Martin JD; Hähnel R; McCartney AJ; De Klerk N
Gynecol Oncol; 1986 Mar; 23(3):329-35. PubMed ID: 3957119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
